1,298
Views
43
CrossRef citations to date
0
Altmetric
Laboratory Study

The Effects of Syzygium aromaticum-Derived Oleanolic Acid on Glycogenic Enzymes in Streptozotocin-Induced Diabetic Rats

, &
Pages 434-439 | Received 15 Nov 2010, Accepted 23 Feb 2011, Published online: 30 Apr 2011

References

  • Murphy ED, Anderson JW. Tissue glycolytic and gluconeogenic enzyme activities in mildly and moderately diabetic rats. Influence of tolbutamide administration. Endocrinology. 1974;94:27–34.
  • Hornbrook KR. Synthesis of liver glycogen in starved alloxan diabetic rats. Diabetes. 1970;19:916–923.
  • Whitton PD, Hems DA. Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats. Biochem J. 1975;150:153–165.
  • Postic C, Shiota M, Magnuson MA. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res. 2001;56:195–217.
  • Iynedjian PB. Mammalian glucokinase and its gene. Biochem J. 1993;293:1–13.
  • Wilson JE. Distinguishing the type I and type II isozymes of hexokinase: The need for a reexamination of past practice. Diabetes. 1998;47:1544–1548.
  • Weber G, Lea MA, Fisher EA, Stamm NB. Regulatory pattern of liver carbohydrate metabolizing enzymes insulin as an inducer of key glycolytic enzymes. Enzymology Clin. 1966;7:11–24.
  • Gershell L. Type 2 diabetes market. Nat Rev Drug Discov. 2005;4:367–368.
  • Taylor R, Agius L. The biochemistry of diabetes. Biochem J. 1988;250(3):625–640.
  • Musabayane CT, Mahlalela N, Shode FO, Ojewole JAO. Effects of Syzygium cordatum (Hochst.)[Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2005;97:485–490.
  • Musabayane CT, Tufts MA, Mapanga RF. Synergistic anti-hyperglycemic effects between plant derived oleanolic acid and insulin in streptozotocin-induced diabetic rats. Ren Fail. 2010;32(7):832–839.
  • Jang SM, Kim MJ, Choi MS, Kwon EY, Lee MK. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metabolism. 2009;59(4):512–519.
  • Mapanga RF, Tufts MA, Shode FO, Musabayane CT. Renal effects of plant derived oleanolic acid in streptozotocin-induced diabetic rats. Ren Fail. 2009;31(6):481–491.
  • Ong KC, Khoo HE. Effects of myricetin on glycaemia and glycogen metabolism in diabetic rats. Life Sci. 2000;67:1695–1705.
  • Gondwe M, Kamadyaapa DR, Tufts MA, Chuturgoon AA, Ojewole JAO, Musabayane CT. Effects of Persea americana Mill (Lauraceae)[“Avocado”] ethanolic extract on blood glucose and kidney function in streptozotocin-induced diabetic rats and on kidney cell lines of the proximal (LLC-PK1) and distal tubules (MDBK). Methods Find Exp Clin Pharmacol. 2008;30(1):25–35.
  • Goward CR, Hartwell R, Atkinson T, Scawen MD. The purification and characterization of glucokinase from the thermophile Bacillus stearothermophilus. J Biochem. 1986;237:415–420.
  • Salas J, Salas M, Vinuela E, Sols A. Glukokinase of rabbit liver. J Biol Chem. 1965;240:1014–1018.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagents. J Biol Chem. 1951;193:265–275.
  • Dent P, Lavoinne A, Nakienly S, Watt P, Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature. 1990;348 (6299):302–308.
  • Flodstrom M, Tyrberg B, Eizirik DL, Sandler S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes. 1999;48:706–713.
  • Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6): 537–546.
  • Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercitin in streptozotocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol. 2003;135C(3):357–364.
  • Vats V, Yadav SP, Grover JK. Effect of T. foenumgraecum on glycogen content of tissues and the key enzymes of carbohydrate metabolism. J Ethnopharmacol. 2003;85:237–242.
  • Denis DM, Miri A, Bielicki G, Mignon M, Renou JP, Grizard J. Insulin-dependent glycogen synthesis is delayed in onset in the skeletal muscle of food-deprived rats. J Nutr Biochem. 2005;16:150–154.
  • Barnard RJ, Youngren JF. Regulation of glucose transport in skeletal muscle. FASEB J. 1992;6:3238–3244.
  • Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799–806.
  • Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycaemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod. 2003;66:788–792.
  • Jensen J, Jebens E, Brennesvik EO, Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling. Am J Physiol Endocrinol Metab. 2006;290:E154–E162.
  • Wiernsperger NF. Is non-insulin dependent glucose uptake a therapeutic alternative? Part 1: Physiology, mechanisms and role of non-insulin dependent glucose uptake in type 2 diabetes. Diabetes Metabolism. 2005;31:415–426.
  • Newgard CB, Hirsch LJ, Foster DW, McGarry JD. Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. J Biol Chem. 1983;258:8046–8052.
  • Gergely P, Toth B, Farkas L, Bot G. Effects of fructose 1‐phosphate on the activation of liver glycogen synthase. J Biochem. 1985;232:133–137.
  • Kumari K, Mathew BC, Augusti KT. Anti diabetic and hypolipidemic effects of S-methyl cysteine sulfoxide isolated from Allium cepa Linn. Ind J Biochem Biophys. 1995;32:49–54.
  • Chen J, Liu J, Zhang L, Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett. 2006;16(11):2915–2919.
  • Prasad RC, Herzog B, Boone B, Sims L, Waltner-Law M. An extract of Syzygium aromaticum represses genes encoding gluconeogenic enzymes. J Ethnopharmacol. 2005;96:295–301.
  • Gupta D, Raju J, Prakash J, Baquer NZ. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: Effects of insulin and vanadate. Diabetes Res Clin Pract. 1999;46:1–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.